MMIT is now offering the only configurable, web-based market access software—integrated with our Analytics solution—that tracks weekly patient access data performance across geographies, payer channels and specific accounts during critical launch milestones.
Now companies can internally share launch access performance with executives and their teams, allowing them to prioritize pull-through, monitor positive/negative changes and adjust their contracting strategy.
Gauge the Impact of Payers’ New-to-Market Policies on Your New Drug Launch for a 360° View of Market Access.
Compare week over week performance across all payers and generate visuals that tell the story of your brand’s performance.
Filter and drill-down to the most meaningful changes each week to develop a plan of attack for the payers driving the most significant changes.
Eliminate and reduce the burden on their internal analytics teams and let MMIT’s industry-leading coverage information shine a light on market opportunities at launch.
“This capability is something we’ve been looking for since I started. It provides us a more precise picture of launch performance and helps us identify trends in the changing landscape – to paint the broader picture in key territories. Filtering payer policies within employer groups is a valuable bonus!”
— Access Manager at Top 50 Manufacturer
Learn how to track drug launch performance across payers during the first critical months post-launch.
As the leading platform for pharma market access teams, MMIT Analytics analyzes comprehensive formulary, policy and restriction information to evaluate patient access for your brands, competitors and analogs.
MMIT Landscape is an easy-to-navigate application that enables account managers to segment payers by market share, line of business, geographic reach and key relationship.
MMIT launch reports help manufacturers vet potential analog products, outline payer and channel segmentation, and highlight potential restrictions to drug launch policies, speeding up commercialization.
